Lynx1 Capital Management LP - Oct 8, 2025 Form 3 Insider Report for Cullinan Therapeutics, Inc. (CGEM)

Role
10%+ Owner
Signature
Lynx1 Capital Management LP, By: Lynx1 Capital Management GP LLC, its general partner, By: /s/ Weston Nichols, Sole Member
Stock symbol
CGEM
Transactions as of
Oct 8, 2025
Transactions value $
$0
Form type
3
Date filed
10/10/2025, 06:56 PM
Previous filing
Sep 15, 2025
Next filing
Oct 21, 2025
SEC
View on sec.gov

Reporting Owners (2)

Name Relationship Address Signature Signature date CIK
Lynx1 Capital Management LP 10%+ Owner D81 CALLE C, STE 301, PMB 1202, DORADO, PUERTO RICO Lynx1 Capital Management LP, By: Lynx1 Capital Management GP LLC, its general partner, By: /s/ Weston Nichols, Sole Member 2025-10-10 0001910456
Nichols Weston 10%+ Owner D81 CALLE C, STE 301, PMB 1202, DORADO, PUERTO RICO /s/ Weston Nichols 2025-10-10 0001746376

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CGEM Common stock, $0.0001 par value per share 7.09M Oct 8, 2025 See footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities to which this filing relates are held directly by Lynx1 Master Fund LP to which Lynx1 Capital Management LP (the "Investment Manager") serves as investment manager. Weston Nichols ("Mr. Nichols") is the sole member of Lynx1 Capital Management GP LLC, the general partner of the Investment Manager. Each of the Investment Manager and Mr. Nichols disclaims beneficial ownership of the securities to which this filing relates for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except to the extent of his or its pecuniary interest therein, if any.